The pharmacokinetics of cyclophosphamide, phosphoramide mustard and nor‐ nitrogen mustard studied by gas chromatography in patients receiving cyclophosphamide therapy.

This publication has 18 references indexed in Scilit:

• Pharmacokinetics of cyclophosphamide and alkylating activity in man after intravenous and oral administration.
  British Journal of Clinical Pharmacology, 1979
• Comparative Effects of Cyclophosphamide, Isophosphamide, 4-Methylcyclophosphamide, and Phosphoramide Mustard on Murine Hematopoietic and Immunocompetent Cells2
  JNCI Journal of the National Cancer Institute, 1979
• QUANTITATION BY GAS CHROMATOGRAPHY CHEMICAL IONIZATION MASS-SPECTROMETRY OF CYCLOPHOSPHAMIDE, PHOSPHORAMIDE MUSTARD, AND NORNITROGEN MUSTARD IN PLASMA AND URINE OF PATIENTS RECEIVING CYCLOPHOSPHAMIDE THERAPY
  1978
• Pharmacokinetics of intravenous cyclophosphamide in man, estimated by gas-liquid chromatography
  Cancer Chemotherapy and Pharmacology, 1978
• The problem of specificity and selectivity of alkylating cytostatics; studies on N-2-chloroethylamido-oxazaphosphorines
  Zeitschrift für Krebsforschung und Klinische Onkologie, 1977
• Isolation and mass spectral identification of blood metabolities of cyclophosphamide: Evidence for phosphoramide mustard as the biologically active metabolite
  Journal of Mass Spectrometry, 1975
• Some studies of the active intermediates formed in the microsomal metabolism of cyclophosphamide and isophosphamide
  Biochemical Pharmacology, 1974
• Clinical pharmacology of cyclophosphamide.
  1973
• Pharmacokinetics of cyclophosphamide in man
  British Journal of Pharmacology, 1971
• Enzymatic basis of cyclophosphamide activation by hepatic microsomes of the rat.
  1970